http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#head http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#assertion http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#provenance http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#publicationInfo http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#assertion http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/bio2rdf_vocabulary:identifier DB05093 http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/bio2rdf_vocabulary:namespace drugbank http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/bio2rdf_vocabulary:uri http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org http://identifiers.org/drugbank/DB05093 http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/drugbank_vocabulary:drugbank-id DB05093 http://bio2rdf.org/drugbank:DB05093 http://bio2rdf.org/drugbank_vocabulary:x-cas http://bio2rdf.org/cas: http://bio2rdf.org/drugbank:DB05093 http://purl.org/dc/terms/description AX200, which has been developed for the treatment of stroke, is the most advanced drug candidate and is halfway through the process of gaining clinical approval. The expression of the endogenous AX200 protein in the brain is increased after brain damage. Thus, if this drug administered in the acute phase of stroke, the brain’s own protective action is supported. And this is where the double neurotherapeutic approach is most beneficial: AX200 stops neuronal cell death in the acute phase of stroke, while stimulating simultaneously the regeneration of nervous tissue through the induction of neuro- and arteriogenesis and supporting the reorganisation of the nervous system. http://bio2rdf.org/drugbank:DB05093 http://purl.org/dc/terms/identifier drugbank:DB05093 http://bio2rdf.org/drugbank:DB05093 http://purl.org/dc/terms/title AX200 http://bio2rdf.org/drugbank:DB05093 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug http://bio2rdf.org/drugbank:DB05093 http://www.w3.org/2000/01/rdf-schema#label AX200 [drugbank:DB05093] http://bio2rdf.org/drugbank:DB05093 http://www.w3.org/2000/01/rdf-schema#seeAlso http://www.drugbank.ca/drugs/DB05093 http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#provenance http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://www.w3.org/ns/dcat#distribution http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://purl.org/dc/terms/created 2015-01-09T17:00:50-05:00 http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://www.w3.org/ns/prov#wasDerivedFrom http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://purl.org/pav/retrievedOn 2014-11-12T07:57:03-05:00 http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://www.w3.org/ns/prov#wasDerivedFrom http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip http://www.w3.org/ns/prov#wasAttributedTo http://drugbank.ca http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#publicationInfo http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#signature.MC0CFBAZly_eBSca http://purl.org/nanopub/x/hasPublicKey MIIBtzCCASwGByqGSM44BAEwggEfAoGBAP1/U4EddRIpUt9KnC7s5Of2EbdSPO9EAMMeP4C2USZpRV1AIlH7WT2NWPq/xfW6MPbLm1Vs14E7gB00b/JmYLdrmVClpJ+f6AR7ECLCT7up1/63xhv4O1fnxqimFQ8E+4P208UewwI1VBNaFpEy9nXzrith1yrv8iIDGZ3RSAHHAhUAl2BQjxUjC8yykrmCouuEC/BYHPUCgYEA9+GghdabPd7LvKtcNrhXuXmUr7v6OuqC+VdMCz0HgmdRWVeOutRZT+ZxBxCBgLRJFnEj6EwoFhO3zwkyjMim4TwWeotUfI0o4KOuHiuzpnWRbqN/C/ohNWLx+2J6ASQ7zKTxvqhRkImog9/hWuWfBpKLZl6Ae1UlZAFMO/7PSSoDgYQAAoGAETGrDm8R3KfndKRj7ttr3jVhhstI6/2Ey0ER9F5kdx7Hrd6eolq7yWzPzf2H754tdZxICzxYcdawBbL2ZUzFjWwXTNUQC3+e6evKPJyNELubnZcA+8TxIIwicBnw3Ku6mSeI8SUVr5SBV1VeJoSu/ahldv562IdBR8IagmzuT3Y= http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#signature.MC0CFBAZly_eBSca http://purl.org/nanopub/x/hasSignature MC0CFBAZly/eBSca59Jd95JJUGIUWx0jAhUAivHJLMgCeGkXTfe3jFH5ZzFZd4E= http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#signature.MC0CFBAZly_eBSca http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://purl.org/dc/terms/created 2018-03-30T11:11:05.708+02:00 http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac#signature.MC0CFBAZly_eBSca http://bio2rdf.org/drugbank:DB05093_nanopub.RAS-ngno7-wHmziap-nxz6_TvWUKn8J_uGLb6w_5In3Ac http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://purl.org/dc/terms/identifier 7720f136-841b-4851-a6e4-ad20a409a475 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234